# Study to Investigate Safety, Tolerability and Pharmacokinetics of AZD2423 Multiple Doses in Healthy Volunteers

> **NCT00977626** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 74 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Part 1 - AZD2423 or Placebo
- **DRUG:** Part 2 - AZD2423
- **DRUG:** Part 3 - AZD2423

## Key facts

- **NCT ID:** NCT00977626
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2012-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00977626

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00977626, "Study to Investigate Safety, Tolerability and Pharmacokinetics of AZD2423 Multiple Doses in Healthy Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00977626. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*